Pulmonary arterial hypertension in France: results from a national registry.
By M. Humbert, O. Sitbon, A. Chaouat, M. Bertocchi, G. Habib, V. Gressin, A. Yaici, E. Weitzenblum, J. Cordier, F. Chabot and 7 more. American Journal of Respiratory and Critical Care Medicine, 2006
1,831 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Oncology, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/68e0e87db2fa75c08a84df8c2cdfe2c518cb9932
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Pulmonary and Respiratory Medicine
Citations in the corpus
- Pediatric Pulmonary Hypertension: Guidelines From the American Heart Association and American Thoracic Society (2015, background): “This is likely an underestimation because patients are often not definitively diagnosed.(162) The diagnosis can be made across the entire age spectrum as early as the neonatal period.”
- Diagnosis and assessment of pulmonary arterial hypertension. (2009, background): “A national registry in France showed a -year survival rate in PAH of 88% in the incident cohort (65).”
- Definitions and diagnosis of pulmonary hypertension. (2013, background): “In the recent REVEAL (Registry to Evaluate Early and Long-Term PAH Disease Management) registry, 21% of patients had symptoms for >2 years before diagnosis (37,38).”
- Pulmonary arterial hypertension (2013, background): “3% of familial PAH in the subgroup of idiopathic, familial or anorexigen-associated PAH [108].”